CN103285248A - Antiphlogistic traditional Chinese medicine - Google Patents
Antiphlogistic traditional Chinese medicine Download PDFInfo
- Publication number
- CN103285248A CN103285248A CN2013102319873A CN201310231987A CN103285248A CN 103285248 A CN103285248 A CN 103285248A CN 2013102319873 A CN2013102319873 A CN 2013102319873A CN 201310231987 A CN201310231987 A CN 201310231987A CN 103285248 A CN103285248 A CN 103285248A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- rhizoma
- antiphlogistic
- traditional chinese
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Abstract
The invention discloses an antiphlogistic traditional Chinese medicine, which is prepared from the following medicinal raw materials by weight: 0-25g of blackberry lily, 0-25g of coptis chinensis, 0-30g of roasted folia eriobotryae, 0-25g of saffron crocus, 0-20g of gastrodia elata, and 0-30g of cinnamon. The antiphlogistic traditional Chinese medicine has a significant treatment effect.
Description
Technical field
The present invention is field of pharmaceutical technology, relates to a kind of Chinese medicine of antiinflammatory.
Background technology
Inflammation refers to that biological tissue is subjected to stimulations such as wound, hemorrhage or pathogen infection, the physiological reaction that excites.The traditional Chinese medical science is thought " inflammation " nothing more than being that heresy is just struggled against, imbalance of YIN and YANG, abnormal ascending-descending of QI.
Summary of the invention
The Chinese medicine that the purpose of this invention is to provide a kind of antiinflammatory of a kind of antiinflammatory obvious results.
The Chinese medicine of a kind of antiinflammatory of the present invention is made by the following raw materials in weight medicine: Rhizoma Belamcandae 0-25g, Rhizoma Coptidis 0-25g, Folium Eriobotryae (processed) 0-30g, Stigma Croci 0-25g, Rhizoma Gastrodiae 0-20g, Cortex Cinnamomi 0-30g;
Made by the following raw materials in weight medicine: Rhizoma Belamcandae 4-20g, Rhizoma Coptidis 4-18g, Folium Eriobotryae (processed) 7-18g, Stigma Croci 4-18g, Rhizoma Gastrodiae 5-15g, Cortex Cinnamomi 7-20g;
Made by the following raw materials in weight medicine: Rhizoma Belamcandae 17g, Rhizoma Coptidis 13g, Folium Eriobotryae (processed) 13g, Stigma Croci 13g, Rhizoma Gastrodiae 9g, Cortex Cinnamomi 13g.
Above-mentioned Chinese medicine is the dosage of 1 auxiliary medicine, and above-mentioned Chinese medicine is put in the marmite, adds three bowls of water, and big fire is boiled, and moderate heat decocts, and when decocting the residue Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz., it is oral to pour out medicine juice, and every day three times, an auxiliary medicine can be drunk 2 days.
The property of medicine, the pharmacology of the crude drug that the present invention adopts and act on as follows:
The Rhizoma Belamcandae bitter in the mouth, cold in nature, cure mainly heat-clearing and toxic substances removing, throat, expectorant saliva.
The Rhizoma Coptidis bitter in the mouth, cold in nature, cure mainly heat clearing and damp drying, eliminating fire and detoxication.Be used for damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, the carbuncle furuncle is quenched one's thirst in toothache; External treatment eczema, eczema, auditory meatus is suppurated.
The Folium Eriobotryae (processed) bitter in the mouth, cold nature cures mainly clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI.The cough due to lung-heat, QI rising in reverse order dyspnea with rapid respiration, gastropyretic vomiting, hiccup.Can treat xerostomia and quench one's thirst, lung-wind syndrome acne vulgaris, acne.
The Stigma Croci sweet in the mouth, little hardship, cool in nature, cure mainly removing heat from the liver, blood stasis stasis, menoxenia, prolonged lochia, traumatic injury, interior external haemorrhage, pneumonia, health weak, train first body-building, be hepatopathy good medicine.
The Rhizoma Gastrodiae sweet in the mouth, property is flat, cures mainly the endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Cortex Cinnamomi acrid in the mouth, sweet, extremely hot in nature cures mainly sexual impotence, cold womb, trusted subordinate's cold type of pain, deficiency and coldness vomiting and diarrhoea, amenorrhea, dysmenorrhea, warming the meridian and promoting blood circulation.
The present invention has passed through clinical trial for many years again according to the modern Chinese medicine pharmacology, constantly gropes the Chinese medicine of a kind of antiinflammatory of forming.Can reach more than 99% through the clinical treatment effective percentage, cure rate reaches more than 95%, and drug effect is remarkable, and curative effect makes us extremely being satisfied with.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment.
The Chinese medicine of a kind of antiinflammatory of the present invention is made by the following raw materials in weight medicine: Rhizoma Belamcandae 17g, Rhizoma Coptidis 13g, Folium Eriobotryae (processed) 13g, Stigma Croci 13g, Rhizoma Gastrodiae 9g, Cortex Cinnamomi 13g.
Above-mentioned Chinese medicine is the dosage of 1 auxiliary medicine, and above-mentioned Chinese medicine is put in the marmite, adds three bowls of water, and big fire is boiled, and moderate heat decocts, and when decocting the residue Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz., it is oral to pour out medicine juice, and every day three times, an auxiliary medicine can be drunk 2 days.
Sum up according to the clinical observation curative effect:
Case 1, patient, man, 18 years old, patient's symptom: pharyngolaryngitis, lymphadenectasis.Treatment: oral above-mentioned Chinese medicine preparation, sx after the course for the treatment of continues to take disease recovery from illness after a course for the treatment of, notes regulating not recurrence behind the health.
Case 2, the patient, the man, 39 years old, patient's symptom: cough, increased the weight of night, thick sputum.Treatment: oral above-mentioned Chinese medicine preparation, symptom recovery from illness after the course for the treatment of notes not having recurrence behind the adjusting health.
Case 3, patient, woman, 23 years old, patient's symptom: have a toothache, be hard and dry.Treatment: oral above-mentioned Chinese medicine preparation, sx after the course for the treatment of continues to take disease recovery from illness after a course for the treatment of, notes regulating not recurrence behind the health.
Case 4, the patient, the woman, 46 years old, patient's symptom: stomachache, tenesmus, fever is had blood in stool.Treatment: oral above-mentioned Chinese medicine preparation, sx after the course for the treatment of continues to take disease recovery from illness after a course for the treatment of, notes regulating not recurrence behind the health.
Embodiment recited above is described preferred implementation of the present invention; be not that the spirit and scope of the present invention are limited; do not breaking away under the design prerequisite of the present invention; common engineers and technicians make technical scheme of the present invention in this area various modification and improvement; all should fall into protection scope of the present invention; the technology contents that the present invention asks for protection all is documented in claims.
Claims (3)
1. the Chinese medicine of an antiinflammatory is characterized in that: made by the following raw materials in weight medicine: Rhizoma Belamcandae 0-25g, Rhizoma Coptidis 0-25g, Folium Eriobotryae (processed) 0-30g, Stigma Croci 0-25g, Rhizoma Gastrodiae 0-20g, Cortex Cinnamomi 0-30g.
2. the Chinese medicine of a kind of antiinflammatory according to claim 1 is characterized in that: made by the following raw materials in weight medicine: Rhizoma Belamcandae 4-20g, Rhizoma Coptidis 4-18g, Folium Eriobotryae (processed) 7-18g, Stigma Croci 4-18g, Rhizoma Gastrodiae 5-15g, Cortex Cinnamomi 7-20g.
3. the Chinese medicine of a kind of antiinflammatory according to claim 1 is characterized in that: Rhizoma Belamcandae 17g, Rhizoma Coptidis 13g, Folium Eriobotryae (processed) 13g, Stigma Croci 13g, Rhizoma Gastrodiae 9g, Cortex Cinnamomi 13g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310231987.3A CN103285248B (en) | 2013-06-05 | 2013-06-05 | Antiphlogistic traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310231987.3A CN103285248B (en) | 2013-06-05 | 2013-06-05 | Antiphlogistic traditional Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103285248A true CN103285248A (en) | 2013-09-11 |
| CN103285248B CN103285248B (en) | 2015-03-18 |
Family
ID=49087137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310231987.3A Expired - Fee Related CN103285248B (en) | 2013-06-05 | 2013-06-05 | Antiphlogistic traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103285248B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109276655A (en) * | 2018-06-25 | 2019-01-29 | 张坤 | A kind of apparent Chinese medicine preparation of anti-inflammatory effects |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105381266A (en) * | 2015-09-29 | 2016-03-09 | 李素影 | Anti-inflammation traditional Chinese medicine |
-
2013
- 2013-06-05 CN CN201310231987.3A patent/CN103285248B/en not_active Expired - Fee Related
Non-Patent Citations (11)
| Title |
|---|
| 叶震欧: "炎症随笔", 《江西中医药》 * |
| 康文娟: "藏红花(卡奇鸽尔更)的研究进展 ", 《青海医学院学报》 * |
| 康文娟: "藏红花(卡奇鸽尔更)的研究进展", 《青海医学院学报》, vol. 24, no. 02, 31 December 2003 (2003-12-31) * |
| 胡一冰等: "中药天麻研究进展 ", 《贵阳中医学院学报》 * |
| 胡一冰等: "中药天麻研究进展", 《贵阳中医学院学报》, vol. 23, no. 04, 31 December 2001 (2001-12-31), pages 48 - 51 * |
| 葛金芳等: "枇杷叶三萜酸的抗炎作用 ", 《安徽医科大学学报》 * |
| 葛金芳等: "枇杷叶三萜酸的抗炎作用", 《安徽医科大学学报》, vol. 42, no. 02, 23 April 2007 (2007-04-23) * |
| 赵保胜等: "黄连解毒汤解热、抗炎作用研究 ", 《中国实验方剂学杂志》 * |
| 赵保胜等: "黄连解毒汤解热、抗炎作用研究", 《中国实验方剂学杂志》, vol. 15, no. 11, 30 November 2009 (2009-11-30), pages 55 - 57 * |
| 郑虎占: "中药合理应用 第2讲 清热药的合理应用 ", 《中国临床医生》 * |
| 郑虎占: "中药合理应用 第2讲 清热药的合理应用", 《中国临床医生》, vol. 36, no. 07, 31 December 2008 (2008-12-31), pages 24 - 26 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109276655A (en) * | 2018-06-25 | 2019-01-29 | 张坤 | A kind of apparent Chinese medicine preparation of anti-inflammatory effects |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103285248B (en) | 2015-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103285248B (en) | Antiphlogistic traditional Chinese medicine | |
| CN102293968B (en) | Traditional Chinese medicine for preventing and treating hiccup disease | |
| CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN102526643B (en) | Chinese herbal medicine buccal tablet for treating dental ulcer | |
| CN105770711A (en) | Gujinwan pharmaceutical composition (pharmaceutical composition for strengthening bones and muscles) and preparation method of pharmaceutical composition | |
| CN103301324A (en) | Traditional Chinese medicine for treating nerve headache | |
| CN104491448A (en) | Traditional Chinese medicine composition for treating prosopalgia caused by wind-heat attacking superficies | |
| CN104740540A (en) | Heat-clearing and detoxifying preparation for treating appendicitis | |
| CN104383232A (en) | Broadleaf holly leaf lozenge with effects of clearing away heat and toxic materials and production method thereof | |
| CN101961474B (en) | Chinese medicinal preparation for treating gastrointestinal diseases | |
| CN103285249A (en) | Antiphlogistic and analgesic traditional Chinese medicine | |
| CN102671027B (en) | Traditional Chinese medicine for curing calculi in urinary system | |
| CN105012775A (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN101940647A (en) | Chinese medicinal herb for treating tympanites (syndromes) | |
| CN105055817A (en) | Patch for treating oral ulcer and preparation method thereof | |
| CN105055758A (en) | Traditional Chinese medicine for treating stomatitis | |
| CN104873836A (en) | Otitis media suppurativa treatment external use medicine and preparation method | |
| CN104758841A (en) | Traditional Chinese medicine preparation for treating appendicitis and preparation method of traditional Chinese medicine preparation | |
| CN104940635A (en) | Scald and burn traditional Chinese medicine compound for external use | |
| CN104840823A (en) | Traditional Chinese medicine preparation for treating otitis media and preparation method | |
| CN104721534A (en) | Preparation for treating acute pharyngitis and preparation method thereof | |
| CN105434906A (en) | Drug for treatment of mouth and tongue sore | |
| CN103721028A (en) | Medicament for treating angina pectoris and preparation method thereof | |
| CN104274718A (en) | Traditional Chinese medicine for treating otitis media suppurative | |
| CN109276655A (en) | A kind of apparent Chinese medicine preparation of anti-inflammatory effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150318 Termination date: 20150605 |
|
| EXPY | Termination of patent right or utility model |